- Home
- MGYR vs COEP Comparison
MGYR vs COEP Comparison
Compare MGYR & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MGYR | COEP |
|---|---|---|
| Founded | 1922 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 111.2M | 100.4M |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | MGYR | COEP |
|---|---|---|
| Price | $17.64 | $13.51 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.1K | ★ 68.3K |
| Earning Date | 01-22-2026 | 11-14-2025 |
| Dividend Yield | ★ 2.04% | N/A |
| EPS Growth | ★ 27.11 | N/A |
| EPS | ★ 1.56 | N/A |
| Revenue | ★ $35,207,000.00 | $500,996.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.31 | ★ N/A |
| Revenue Growth | ★ 11.78 | N/A |
| 52 Week Low | $13.52 | $6.26 |
| 52 Week High | $19.04 | $21.41 |
Technical Indicators
Market Signals| Indicator | MGYR | COEP |
|---|---|---|
| Relative Strength Index (RSI) | 54.78 | 35.02 |
| Support Level | $17.50 | $13.74 |
| Resistance Level | $17.68 | $14.77 |
| Average True Range (ATR) | 0.05 | 0.84 |
| MACD | -0.00 | -0.12 |
| Stochastic Oscillator | 50.79 | 0.66 |
Price Performance
Historical ComparisonAbout MGYR Magyar Bancorp Inc.
Magyar Bancorp Inc is a mid-tier stock holding company. The Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and home equity loans; and the provision of other financial services. The business consists of getting retail deposits from the general public in the areas surrounding the main office in New Brunswick, New Jersey and branch offices located in Middlesex and Somerset Counties, New Jersey, and investing those deposits, together with funds generated from operations and wholesale funding, in residential mortgage loans, home equity loans, home equity lines of credit, commercial real estate loans, commercial business loans, Small Business Administration loans.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.